Patent Assignment
Reel/Frame 015284/0682
Assignment of Assignor's Interest
Recorded: 2004-10-22
Pages: 6
Assignor
MESSAGE PHARMACEUTICALS, INC.
Executed: 2004-09-07
Assignee
NUCLEONICS, INC.
702 ELECTRONIC DRIVE, HORSHAM, PENNSYLVANIA, 19044
Covered Properties
(3)
Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
Application:
10/062,707 →
Publication:
US 2002/0132257
Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
Application:
60/265,805 →
Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
Application:
60/339,260 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Apr 16, 2002
From: MESSAGE PHARMACUECTICALS, INC.
To: TOUCAN CAPITAL FUND II, L.P.
Reel/Frame 012590/0531 →
Security Agreement
Apr 16, 2002
From: MESSAGE PHARMACUECTICALS, INC.
To: TOUCAN CAPITAL FUND II, L.P.
Reel/Frame 012590/0561 →
Assignment of Assignor's Interest
May 22, 2002
From: GIORDANO, TONY; PACHUK, CATHERINE J.; SATISCHANDRAN, C.
To: NUCLEONICS, INC.
Reel/Frame 013545/0719 →
Security Agreement
Sep 29, 2008
From: NUCLEONICS, INC.
To: NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP; S.R. ONE, LIMITED; OFCO CLUB IV; HEALTHCAP IV KB
Reel/Frame 021602/0423 →
Release of Security Interest
Dec 5, 2008
From: NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP; BURRILL LIFE SCIENCES CAPITAL FUND, L.P.; BURRILL INDIANA LIFE SCIENCES CAPITAL FUND, L.P.; OFCO CLUB IV
To: NUCLEONICS, INC.
Reel/Frame 021932/0001 →
Assignment of Assignor's Interest
Mar 12, 2009
From: NUCLEONICS, INC.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 022386/0468 →